Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Annals of Nuclear Medicine
Published in: Annals of Nuclear Medicine 3/2023

20-12-2022 | Pneumonia | Original Article

Invasive mucinous adenocarcinoma of the lung: clinicopathological features, 18F-FDG PET/CT findings, and survival outcomes

Authors: Xiaolin Sun, Baozhen Zeng, Xiaoyue Tan, Zhijian Chen, Xiaoqiang Pan, Lei Jiang

Published in: Annals of Nuclear Medicine | Issue 3/2023

Login to get access

Abstract

Objective

Invasive mucinous adenocarcinoma (IMA) is a rare subtype of lung adenocarcinoma. This study aimed to retrospectively evaluate the clinicopathological features, 18F-FDG PET/CT findings, and prognosis of IMA of the lung, as well as to investigate the associations among these variables, to improve the management of such patients.

Methods

Clinicopathological and 18F-FDG PET/CT characteristics of 72 patients with pathologically confirmed IMA of the lung were retrospectively collected and investigated, and their predictive efficacy on progression-free survival (PFS) was evaluated.

Results

The median age of the enrolled 72 patients was 61 years (range, 26–79 years), and the male-to-female ratio was 1:1.25. According to the radiological morphology of IMA, solidary nodule/mass type (n = 59, 81.9%) was the most common, followed by GGO type (n = 8, 11.1%) and pneumonia type (n = 5, 6.9%). Lobulated or spiculated margin and pleural traction were the most common radiological signs. The median SUVmax of IMA lesions was 3.0, ranging from 0.5 to 23.1. Higher SUVmax was observed in IMA with non-GGO type, clinical symptom, advanced stage, lobulated margin, pleural traction or spread through air spaces (STAS) (P < 0.05). Moreover, higher SUVmax was related to larger tumor size in non-pneumonia-type IMA (r = 0.708, P < 0.001). The median PFS was 21.3 months, and the 12-, 24- and 36-month PFS rates were 89.8%, 83.3% and 75.5%, respectively. A poorer PFS was significantly associated with SUVmax ≥ 3, advanced stage and STAS.

Conclusion

18F-FDG PET/CT combined with clinicopathological characteristics can aid the diagnosis and prognostic evaluation of lung IMA, which could provide guidance for the appropriate management of such patients.
Literature
1.
Suzuki S, Aokage K, Hishida T, Yoshida J, Kuwata T, Yamauchi C, et al. Interstitial growth as an aggressive growth pattern in primary lung cancer. J Cancer Res Clin Oncol. 2016;142(7):1591–8.CrossRefPubMed
2.
Masai K, Sakurai H, Sukeda A, Suzuki S, Asakura K, Nakagawa K, et al. Prognostic Impact of Margin Distance and Tumor Spread Through Air Spaces in Limited Resection for Primary Lung Cancer. J Thorac Oncol. 2017;12(12):1788–97.CrossRefPubMed
3.
Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6(2):244–85.CrossRefPubMedPubMedCentral
4.
Kish JK, Ro JY, Ayala AG, McMurtrey MJ. Primary mucinous adenocarcinoma of the lung with signet-ring cells: a histochemical comparison with signet-ring cell carcinomas of other sites. Hum Pathol. 1989;20(11):1097–102.CrossRefPubMed
5.
Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to The 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart. J Thorac Oncol. 2015;10(9):1240–2.CrossRefPubMed
6.
Nie K, Nie W, Zhang YX, Yu H. Comparing clinicopathological features and prognosis of primary pulmonary invasive mucinous adenocarcinoma based on computed tomography findings. Cancer Imaging. 2019;19(1):47.CrossRefPubMedPubMedCentral
7.
Watanabe H, Saito H, Yokose T, Sakuma Y, Murakami S, Kondo T, et al. Relation between thin-section computed tomography and clinical findings of mucinous adenocarcinoma. Ann Thorac Surg. 2015;99(3):975–81.CrossRefPubMed
8.
Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000;41(8):1369–79.PubMed
9.
Wang T, Yang Y, Liu X, Deng J, Wu J, Hou L, et al. Primary invasive mucinous adenocarcinoma of the lung: prognostic value of CT imaging features combined with clinical factors. Korean J Radiol. 2021;22(4):652–62.CrossRefPubMed
10.
Han Y, Luo Y. Primary lung invasive adenocarcinoma misdiagnosed as infectious pneumonia in (18)F-FDG PET/CT: A case report. Radiol Case Rep. 2022;17(3):808–11.CrossRefPubMed
11.
12.
Lee HY, Choi YL, Lee KS, Han J, Zo JI, Shim YM, et al. Pure ground-glass opacity neoplastic lung nodules: histopathology, imaging, and management. AJR Am J Roentgenol. 2014;202(3):W224–33.CrossRefPubMed
13.
Wislez M, Massiani MA, Milleron B, Souidi A, Carette MF, Antoine M, et al. Clinical characteristics of pneumonic-type adenocarcinoma of the lung. Chest. 2003;123(6):1868–77.CrossRefPubMed
14.
Duruisseaux M, Antoine M, Rabbe N, Poulot V, Fleury-Feith J, Vieira T, et al. The impact of intracytoplasmic mucin in lung adenocarcinoma with pneumonic radiological presentation. Lung Cancer. 2014;83(3):334–40.CrossRefPubMed
15.
Boland JM, Maleszewski JJ, Wampfler JA, Voss JS, Kipp BR, Yang P, et al. Pulmonary invasive mucinous adenocarcinoma and mixed invasive mucinous/nonmucinous adenocarcinoma-a clinicopathological and molecular genetic study with survival analysis. Hum Pathol. 2018;71:8–19.CrossRefPubMed
16.
Dirican N, Baysak A, Cok G, Goksel T, Aysan T. Clinical characteristics of patients with bronchioloalveolar carcinoma: a retrospective study of 44 cases. Asian Pac J Cancer Prev. 2013;14(7):4365–8.CrossRefPubMed
17.
Casali C, Rossi G, Marchioni A, Sartori G, Maselli F, Longo L, et al. A single institution-based retrospective study of surgically treated bronchioloalveolar adenocarcinoma of the lung: clinicopathologic analysis, molecular features, and possible pitfalls in routine practice. J Thorac Oncol. 2010;5(6):830–6.CrossRefPubMed
18.
Kandathil A, Sibley RC III, Subramaniam RM. Lung Cancer Recurrence: (18)F-FDG PET/CT in Clinical Practice. AJR Am J Roentgenol. 2019;213(5):1136–44.CrossRefPubMed
19.
Chang JM, Lee HJ, Goo JM, Lee HY, Lee JJ, Chung JK, et al. False positive and false negative FDG-PET scans in various thoracic diseases. Korean J Radiol. 2006;7(1):57–69.CrossRefPubMedPubMedCentral
20.
Cha MJ, Lee KS, Kim TJ, Kim HS, Kim TS, Chung MJ, et al. Solitary nodular invasive mucinous adenocarcinoma of the lung: imaging diagnosis using the morphologic-metabolic dissociation sign. Korean J Radiol. 2019;20(3):513–21.CrossRefPubMedPubMedCentral
21.
Lee H, Lee K, Han J, Kim B, Cho Y, Shim Y, et al. Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons. Lung Cancer (Amsterdam, Netherlands). 2009;65(2):170–5.CrossRefPubMed
22.
Murakami S, Saito H, Karino F, Kondo T, Oshita F, Ito H, et al. 18F-fluorodeoxyglucose uptake on positron emission tomography in mucinous adenocarcinoma. Eur J Radiol. 2013;82(11):e721–5.CrossRefPubMed
23.
Lee HY, Cha MJ, Lee KS, Lee HY, Kwon OJ, Choi JY, et al. Prognosis in resected invasive mucinous adenocarcinomas of the lung: related factors and comparison with resected nonmucinous adenocarcinomas. J Thorac Oncol. 2016;11(7):1064–73.CrossRefPubMed
24.
Kadota K, Nitadori JI, Sima CS, Ujiie H, Rizk NP, Jones DR, et al. Tumor spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences after limited resection for small Stage I lung adenocarcinomas. J Thorac Oncol. 2015;10(5):806–14.CrossRefPubMedPubMedCentral
25.
Warth A, Muley T, Kossakowski CA, Goeppert B, Schirmacher P, Dienemann H, et al. Prognostic impact of intra-alveolar tumor spread in pulmonary adenocarcinoma. Am J Surg Pathol. 2015;39(6):793–801.CrossRefPubMed
26.
Nishimori M, Iwasa H, Miyatake K, Nitta N, Nakaji K, Matsumoto T, et al. 18F FDG-PET/CT analysis of spread through air spaces (STAS) in clinical stage I lung adenocarcinoma. Ann Nucl Med. 2022;36(10):897–903.CrossRefPubMed
27.
Yoshizawa A, Motoi N, Riely GJ, Sima CS, Gerald WL, Kris MG, et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol. 2011;24(5):653–64.CrossRefPubMed
28.
Russell PA, Wainer Z, Wright GM, Daniels M, Conron M, Williams RA. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol. 2011;6(9):1496–504.CrossRefPubMed
29.
Warth A, Muley T, Meister M, Stenzinger A, Thomas M, Schirmacher P, et al. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol. 2012;30(13):1438–46.CrossRefPubMed
30.
Yoshizawa A, Sumiyoshi S, Sonobe M, Kobayashi M, Fujimoto M, Kawakami F, et al. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients. J Thorac Oncol. 2013;8(1):52–61.CrossRefPubMed
31.
Groheux D, Quere G, Blanc E, Lemarignier C, Vercellino L, de Margerie-Mellon C, et al. FDG PET-CT for solitary pulmonary nodule and lung cancer: Literature review. Diagn Interv Imaging. 2016;97(10):1003–17.CrossRefPubMed
32.
Tosi D, Pieropan S, Cattoni M, Bonitta G, Franzi S, Mendogni P, et al. Prognostic value of 18F-FDG PET/CT metabolic parameters in surgically treated stage I lung adenocarcinoma patients. Clin Nucl Med. 2021;46(8):621–6.CrossRefPubMedPubMedCentral
33.
Khiewvan B, Ziai P, Houshmand S, Salavati A, Ziai P, Alavi A. The role of PET/CT as a prognosticator and outcome predictor in lung cancer. Expert Rev Respir Med. 2016;10(3):317–30.CrossRefPubMed
34.
Shimizu K, Okita R, Saisho S, Maeda A, Nojima Y, Nakata M. Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings. Onco Targets Ther. 2017;10:153–63.CrossRefPubMed
35.
Uruga H, Fujii T, Fujimori S, Kohno T, Kishi K. Semiquantitative assessment of tumor spread through air spaces (STAS) in early-stage lung adenocarcinomas. J Thorac Oncol. 2017;12(7):1046–51.CrossRefPubMed
36.
Lu S, Tan KS, Kadota K, Eguchi T, Bains S, Rekhtman N, et al. Spread through air spaces (STAS) is an independent predictor of recurrence and lung cancer-specific death in squamous cell carcinoma. J Thorac Oncol. 2017;12(2):223–34.CrossRefPubMed
Metadata
Title
Invasive mucinous adenocarcinoma of the lung: clinicopathological features, 18F-FDG PET/CT findings, and survival outcomes
Authors
Xiaolin Sun
Baozhen Zeng
Xiaoyue Tan
Zhijian Chen
Xiaoqiang Pan
Lei Jiang
Publication date
20-12-2022
Publisher
Springer Nature Singapore
Keyword
Pneumonia
Published in
Annals of Nuclear Medicine / Issue 3/2023
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-022-01816-7

Other articles of this Issue 3/2023

Annals of Nuclear Medicine 3/2023 Go to the issue

Original Article

Incidence of renal scarring on technetium-99 m dimercaptosuccinic acid renal scintigraphy after acute pyelonephritis, acute focal bacterial nephritis, and renal abscess

Original Article

99mTc-Rituximab sentinel lymph node mapping and biopsy, the effective technique avoids axillary dissection and predicts prognosis in 533 cutaneous melanoma

Original Article

Prognostic value of semi-quantitative parameters of 18F-FDG PET/CT in newly diagnosed multiple myeloma patients

Original Article

Melissa Officinalis L. aqueous extract pretreatment decreases methotrexate-induced hepatotoxicity at lower dose and increases 99mTc-phytate liver uptake, as a probe of liver toxicity assessment, in rats